A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder

Schizophrenia Research

Volumn 124, Issue 1-3, 2010, Pages 192-199

  Wang, Ke Sheng ^a   Liu, Xue Feng ^a   Aragam, Nagesh ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Genome wide association; Haplotype; Meta analysis; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

CONTACTIN; MEMBRANE PROTEIN; PROTEIN ASTN2; PROTEIN CNTNAP2; PROTEIN GABRR1; PROTEIN GABRR2; UNCLASSIFIED DRUG;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GABA-A; SCHIZOPHRENIA; SODIUM CHANNELS;

EID: 78249259373     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.09.002     Document Type: Article

References (60)

1. Abrahams B.S., Tentler D., Perederiy J.V., Oldham M.C., Coppola G., Geschwind D.H. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proc. Natl. Acad. Sci. 2007, 104:17849-17854.
2. Adkins D.E., Aberg K., McClay J.L., Bukszár J., Zhao Z., Jia P., Stroup T.S., Perkins D., McEvoy J.P., Lieberman J.A., Sullivan P.F., van den Oord E.J. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Mol. Psychiatry 2010, [Epub ahead of print].
3. Alaerts M., Del-Favero J. Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. Hum. Mutat. 2009, 30:1139-1152.
4. Alarcón M., Abrahams B.S., Stone J.L., Duvall J.A., Perederiy J.V., Bomar J.M., Sebat J., Wigler M., Martin C.L., Ledbetter D.H., Nelson S.F., Cantor R.M., Geschwind D.H. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 2008, 82:150-159.
5. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., Rea A., Guy M., Lin S., Cook E.H., Chakravarti A. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 2008, 82:160-164.
6. Bailer U., Leisch F., Meszaros K., Lenzinger E., Willinger U., Strobl R., Heiden A., Gebhardt C., Döge E., Fuchs K., Sieghart W., Kasper S., Hornik K., Aschauer H.N. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol. Psychiatry 2002, 52:40-52.
7. Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F., Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G., Stillman A.A., Tanriover G., Abrahams B.S., Duvall J.A., Robbins E.M., Geschwind D.H., Biederer T., Gunel M., Lifton R.P., State M.W. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 2008, 82:165-173.
8. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 2:263-265.
9. Berrettini W.H. Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biol. Psychiatry 2000, 47:245-251.
10. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am. J. Med. Genet. C Semin. Med. Genet. 2003, 123C:59-64.
11. Bramon E., Sham P.C. The common genetic liability between schizophrenia and bipolar disorder: a review. Curr. Psychiatry Rep. 2001, 3:332-337.
12. Carroll L.S., Owen M.J. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med. 2009, 1(10):102.
13. Craddock N., O'Donovan M.C., Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 2005, 42:193-204.
14. Craddock N., Jones L., Jones I.R., Kirov G., Green E.K., Grozeva D., Moskvina V., Nikolov I., Hamshere M.L., Vukcevic D., Caesar S., Gordon-Smith K., Fraser C., Russell E., Norton N., Breen G., St Clair D., Collier D.A., Young A.H., Ferrier I.N., Farmer A., McGuffin P., Holmans P.A., Donnelly P., Owen M.J., O'Donovan M.C. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol. Psychiatry 2010, 15:146-153. Wellcome Trust Case Control Consortium (WTCCC).
15. Cutting G.R., Lu L., O'Hara B.F., Kasch L.M., Montrose-Rafizadeh C., Donovan D.M., Shimada S., Antonarakis S.E., Guggino W.B., Uhl G.R., Kazazian H.H. Cloning of the gamma-aminobutyric acid (GAGA) rho-1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc. Natl. Acad. Sci. 1991, 88:2673-2677.
16. Cutting G.R., Curristin S., Zoghbi H., O'Hara B., Seldin M.F., Uhl G.R. Identification of a putative gamma-aminobutyric acid (GABA) receptor subunit rho-2 cDNA and colocalization of the genes encoding rho-2 (GABRR2) and rho-1 (GABRR1) to human chromosome 6q14-q21 and mouse chromosome 4. Genomics 1992, 12:801-806.
17. Detera-Wadleigh S.D., McMahon F.J. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol. Psychiatry 2006, 60:106-114.
18. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum. Hered. 2008, 66:87-98.
19. Dudbridge F., Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet. Epidemiol. 2008, 32:227-234.
20. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., D'arcy M., deBerardinis R., Frackelton E., Kim C., Lantieri F., Muganga B.M., Wang L., Takeda T., Rappaport E.F., Grant S.F., Berrettini W., Devoto M., Shaikh T.H., Hakonarson H., White P.S. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry 2010, 15:637-646.
21. Friedman J.I., Vrijenhoek T., Markx S., Janssen I.M., van der Vliet W.A., Faas B.H., Knoers N.V., Cahn W., Kahn R.S., Edelmann L., Davis K.L., Silverman J.M., Brunner H.G., van Kessel A.G., Wijmenga C., Ophoff R.A., Veltman J.A. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol. Psychiatry 2008, 13:261-266.
22. Friedman J.I., Vrijenhoek T., Markx S., Janssen I.M., van der Vliet W.A., Faas B.H., Knoers N.V., Cahn W., Kahn R.S., Edelmann L., Davis K.L., Silverman J.M., Brunner H.G., Geurts van Kessel A., Wijmenga C., Ophoff R.A., Veltman J.A. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2010, Apr 20. [Epub ahead of print].
23. Garcia J., Castrillo J.-L. Identification of two novel human genes, DIPLA1 and DIPAS, expressed in placenta tissue. Gene 2005, 344:241-250.
24. Georgieva L., Dimitrova A., Ivanov D., Nikolov I., Williams N.M., Grozeva D., Zaharieva I., Toncheva D., Owen M.J., Kirov G., O'Donovan M.C. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol. Psychiatry 2008, 64:419-427.
25. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P., Holmans P.A., Owen M.J., O'Donovan M.C., Craddock N. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 2009, Wellcome Trust Case Control Consortium5, [Epub ahead of print].
26. Green E.K., Grozeva D., Moskvina V., Hamshere M.L., Jones I.R., Jones L., Forty L., Caesar S., Gordon-Smith K., Fraser C., Russell E., St Clair D., Young A.H., Ferrier N., Farmer A., McGuffin P., Holmans P.A., Owen M.J., O'Donovan M.C., Craddock N. Variation at the GABA(A) receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, Jun 25. [Epub ahead of print].
27. Guessous I., Gwinn M., Khoury M.J. Genome-wide association studies in pharmacogenomics: untapped potential for translation. Genome Med. 2009, 1:46.
28. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752. International Schizophrenia Consortium.
29. Karege F., Perroud N., Schürhoff F., Méary A., Marillier G., Burkhardt S., Ballmann E., Fernandez R., Jamain S., Leboyer M., La Harpe R., Malafosse A. Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder. Genes Brain Behav. 2010, [Epub ahead of print].
30. Knight H.M., Pickard B.S., Maclean A., Malloy M.P., Soares D.C., McRae A.F., Condie A., White A., Hawkins W., McGhee K., van Beck M., MacIntyre D.J., Starr J.M., Deary I.J., Visscher P.M., Porteous D.J., Cannon R.E., St Clair D., Muir W.J., Blackwood D.H. A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. Am. J. Hum. Genet. 2009, 85:833-846.
31. Laursen T.M., Agerbo E., Pedersen C.B. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index. J. Clin. Psychiatry 2009, 70:1432-1438.
32. Lesch K.P., Timmesfeld N., Renner T.J., Halperin R., Röser C., Nguyen T.T., Craig D.W., Romanos J., Heine M., Meyer J., Freitag C., Warnke A., Romanos M., Schäfer H., Walitza S., Reif A., Stephan D.A., Jacob C. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J. Neural Transm. 2008, 115:1573-1585.
33. Lichtenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
34. Lin P.I., Mitchell B.D. Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorder. Schizophr. Bull. 2008, 34:791-797.
35. Lu B., Su Y., Das S., Liu J., Xia J., Ren D. The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm. Cell 2007, 129:371-383.
36. Maier W., Zobel A., Wagner M. Schizophrenia and bipolar disorder: differences and overlaps. Curr. Opin. Psychiatry 2006, 19:165-170.
37. Matuoka K., Miki H., Takahashi K., Takenawa T. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs. Biochem. Biophys. Res. Commun. 1997, 239:488-492.
38. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., Hirschhorn J.N. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 2008, 9:356-369.
39. McCarthy S.E., Makarov V., Kirov G., Addington A.M., McClellan J., Yoon S., Perkins D.O., Dickel D.E., Kusenda M., Krastoshevsky O., Krause V., Kumar R.A., Grozeva D., Malhotra D., Walsh T., Zackai E.H., Kaplan P., Ganesh J., Krantz I.D., Spinner N.B., Roccanova P., Bhandari A., Pavon K., Lakshmi B., Leotta A., Kendall J., Lee Y.H., Vacic V., Gary S., Iakoucheva L.M., Crow T.J., Christian S.L., Lieberman J.A., Stroup T.S., Lehtimäki T., Puura K., Haldeman-Englert C., Pearl J., Goodell M., Willour V.L., Derosse P., Steele J., Kassem L., Wolff J., Chitkara N., McMahon F.J., Malhotra A.K., Potash J.B., Schulze T.G., Nöthen M.M., Cichon S., Rietschel M., Leibenluft E., Kustanovich V., Lajonchere C.M., Sutcliffe J.S., Skuse D., Gill M., Gallagher L., Mendell N.R., Craddock N., Owen M.J., O'Donovan M.C., Shaikh T.H., Susser E., Delisi L.E., Sullivan P.F., Deutsch C.K., Rapoport J., Levy D.L., King M.C., Sebat J. Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 2009, 41:1223-1227. Wellcome Trust Case Control Consortium.
40. Möller H.J. Bipolar disorder and schizophrenia: distinct illnesses or a continuum?. J. Clin. Psychiatry 2003, 64(Suppl 6):23-27.
41. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., Wellcome Trust Case Control Consortium, Owen M.J., O'Donovan M.C. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 2009, 14:252-260.
42. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Möller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nöthen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Molecular Genetics of Schizophrenia Collaboration. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40:1053-1055.
43. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., Corvin A. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol. Psychiatry 2010, The International Schizophrenia Consortium, [Epub ahead of print].
44. Ollila H.M., Soronen P., Silander K., Palo O.M., Kieseppä T., Kaunisto M.A., Lönnqvist J., Peltonen L., Partonen T., Paunio T. Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort. Mol. Psychiatry 2009, 14:351-353.
45. Potash J.B., Bienvenu O.J. Neuropsychiatric disorders: shared genetics of bipolar disorder and schizophrenia. Nat. Rev. Neurol. 2009, 5:299-300.
46. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
47. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D.S., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 3:559-575.
48. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 2008, 165:497-506.
49. Scholz C.J., Jacob C.P., Buttenschon H.N., Kittel-Schneider S., Boreatti-Hümmer A., Zimmer M., Walter U., Lesch K.P., Mors O., Kneitz S., Deckert J., Reif A. Functional variants of TSPAN8 are associated with bipolar disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:967-972.
50. Schumacher J., Laje G., Abou Jamra R., Becker T., Mühleisen T.W., Vasilescu C., Mattheisen M., Herms S., Hoffmann P., Hillmer A.M., Georgi A., Herold C., Schulze T.G., Propping P., Rietschel M., McMahon F.J., Nöthen M.M., Cichon S. The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. Hum. Mol. Genet. 2009, 18:2719-2727.
51. Shi J., Badner J.A., Gershon E.S., Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr. Res. 2008, 98(1-3):89-97.
52. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
53. Smith E.N., Bloss C.S., Badner J.A., Barrett T., Belmonte P.L., Berrettini W., Byerley W., Coryell W., Craig D., Edenberg H.J., Eskin E., Foroud T., Gershon E., Greenwood T.A., Hipolito M., Koller D.L., Lawson W.B., Liu C., Lohoff F., McInnis M.G., McMahon F.J., Mirel D.B., Murray S.S., Nievergelt C., Nurnberger J., Nwulia E.A., Paschall J., Potash J.B., Rice J., Schulze T.G., Scheftner W., Panganiban C., Zaitlen N., Zandi P.P., Zöllner S., Schork N.J., Kelsoe J.R. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol. Psychiatry 2009, 14:755-763.
54. Souza R.P., Rosa D.V., Romano-Silva M.A., Zhen M., Meltzer H.Y., Lieberman J.A., Remington G., Kennedy J.L., Wong A.H. Lack of association of NALCN genetic variants with schizophrenia. Psychiatry Res. 2010, Jul 29. [Epub ahead of print].
55. Storey, J.D., 2002. A direct approach to false discovery rates. Journal of the Royal Statistical Society, Series B 64, 479-498.
56. Van Snellenberg J.X., de Candia T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 2009, 66:748-755.
57. Vrijenhoek T., Buizer-Voskamp J.E., van der Stelt I., Strengman E., Sabatti C., Geurts van Kessel A., Brunner H.G., Ophoff R.A., Veltman J.A. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am. J. Hum. Genet. 2008, 83:504-510. Genetic Risk and Outcome in Psychosis (GROUP) Consortium.
58. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678. Wellcome Trust Case Control Consortium.
59. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L., Georgieva L., Williams N.M., Morris D.W., Quinn E.M., Giegling I., Ikeda M., Wood J., Lencz T., Hultman C., Lichtenstein P., Thiselton D., Maher B.S., Malhotra A.K., Riley B., Kendler K.S., Gill M., Sullivan P., Sklar P., Purcell S., Nimgaonkar V.L., Kirov G., Holmans P., Corvin A., Rujescu D., Craddock N., Owen M.J., O'Donovan M.C. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 2010, Molecular Genetics of Schizophrenia Collaboration (MGS) International Schizophrenia Consortium (ISC), SGENE-plus GROUPSGENE-plus GROUP, [Epub ahead of print].
60. Xuei X., Flury-Wetherill L., Dick D., Goate A., Tischfield J., Nurnberger J., Schuckit M., Kramer J., Kuperman S., Hesselbrock V., Porjesz B., Foroud T., Edenberg H.J. GABRR1 and GABRR2, encoding the GABA-A receptor subunits rho1 and rho2, are associated with alcohol dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:418-427.